Volume 4, Issue 8, Part 3.

Raymond T. Chung, MD from Harvard Medical School interviews Dr. David Wyles from the University of California San Diego about his presentation: Sofosbuvir/Velpatasivr Fixed Dose Combination for 12 Weeks in Patients Co-Infected with HCV and HIV-1: The Phase 3 ASTRAL-5 Study, presented at the April 2016 EASL meeting.

The post Sofosbuvir/Velpatasvir fixed dose combination for 12 Weeks in Patients Co-Infected with HCV and HIV-1: The Phase 3 ASTRAL-5 Study appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

Volume 4, Issue 8, Part 2.

Raymond T. Chung, MD from Harvard Medical School interviews Dr. Michael Charlton from Intermountain Medical Center about his abstract: Resistance Analyses for Ledipasvir/Sofosbuvir-Containing Regimens in Patients Infected with Chronic HCV Who Have Advanced Liver Disease or are Post Liver Transplant(SOLAR-1 & 2 Studies), presented at the April 2016 EASL meeting.

The post Resistance Analysis for Ledipasvir/Sofosbuvir containing regimens in patients infected with chronic HCV who have advanced liver disease or are post Liver Transplant (SOLAR-1 and 2 STUDIES) appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

Volume 4, Issue 8, Part 1.

Raymond T. Chung, MD from Harvard Medical School interviews Dr. Eric Lawitz from the University of Texas Health Science Center about his presentation: High Efficacy of Sofosbuvir/Velpatasvir Plus GS-9857 for 12 Weeks in Treatment-Experienced Genotype 1-6 HCV-Infected Patients, Including Those Previously Treated with Direct-Acting Antivirals presented at the April 2016 EASL meeting.

The post High Efficacy of Sofosbuvir/Velpatasvir plus GS-9857 for 12 Weeks in Treatment-experienced Genotype 1-6 HCV-Infected Patients, Including those Previously Treated with Direct-acting Antivirals appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

Volume 4, Issue 7.

Drs Paul Martin, MD and Kalyan Ram Bhamidimarri, MD cover the important topic of Hepatitis C Treatment in the HIV Coinfected and Dialysis Populations in the format of case-study scenarios for the clinical practice.

The post Hepatitis C Treatment in the HIV Coinfected and Dialysis Populations appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

Volume 4, Issue 5.

Arthur Y. Kim, MD covers the important topic of Screening for HCV and HBV Infection in the Clinic in the format of case-study scenarios for the clinical practice.

The post Screening for HCV and HBV Infection in the Clinic appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

Volume 4, Issue 3, Part 3.

Mark S. Sulkowski from the Johns Hopkins University School of Medicine interviews Dr. Gregory Dore from the Kirby Institute, UNSW Australia about the C-EDGE CO-STAR study.

The post Advances in Managing Hard-to-Treat Hepatitis C: Highlights from the American Association for the Study of Liver Diseases (AASLD) Meeting November 2015 appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

Volume 4, Issue 3, Part 2.

Mark S. Sulkowski from the Johns Hopkins University School of Medicine interviews Dr. Graham Foster from Queen Mary University of London about the ASTRAL-3 study.

The post Advances in Managing Hard-to-Treat Hepatitis C: Highlights from the American Association for the Study of Liver Diseases (AASLD) Meeting November 2015 appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

Volume 4, Issue 3, Part 1.

Mark S. Sulkowski from the Johns Hopkins University School of Medicine interviews Dr. Vincent Leroy from Grenoble University Hospital about the ALLY-3+ study.

The post Advances in Managing Hard-to-Treat Hepatitis C: Highlights from the American Association for the Study of Liver Diseases (AASLD) Meeting November 2015 appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

Volume 4, Issue 2.

David L. Wyles, MD covers the important topic of New DAAs and HCVV Genotype 2/3 Patients in the format of case-study scenarios for the clinical practice.

The post The New DAAs and HCV Genotype 2/3 Patients appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.

Special Edition 2014, Issue 2, Part 3.

Raymond T. Chung, MD from Massachusetts General Hospital in Boston interviews Dr. Susanna Naggie from Duke University Medical Center and Dr. Paul Kwo from Indiana University School of Medicine about HCV-HIV coinfection, decompensated cirrhosis, liver transplantation and discusses strategies to treat this hard-to-treat patient subpopulation with program director, Dr. Mark Sulkowski.

The post INDIVIDUALIZING THERAPY IN PATIENT SUBPOPULATIONS INFECTED WITH HCV WHO ARE COINFECTED WITH HIV, HAVE DECOMPENSATED CIRRHOSIS, OR HAVE UNDERGONE LIVER TRANSPLANTATION appeared first on DKBmed Radio.

Hosted on Acast. See acast.com/privacy for more information.